Pharmaron Beijing Co., Ltd. (3759.HK) HKSE

20.74

-0.3(-1.43%)

Updated at December 24 12:08PM

Currency In HKD

Valuation

Market Cap23.67B
Enterprise Value27.52B
P/E Ratio34.36
PEG Ratio3.83
Price/Sales Ratio3.23
Price/Book Ratio3.56
Enterprise/Revenue3.61
Enterprise/EBITDA17.91

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0.11
Operating Margin0.13

Management Effectiveness

Return On Assets0.06
Return On Equity0.11

Income Statement

Revenue12.28B
Revenue/Share7.65
Gross Profit4.2B
EBITDA3.38B
Net Income1.79B
Diluted EPS1.01

Balance Sheet

Total Cash2.49B
Total Cash/Share1.29
Total Debt6.98B
Total Debt/Equity0.44
Current Ratio1.5
Book Value Per Share8.61

Price History

52-Week Change47.93
52-Week High30.12
52-Week Low10.46
Moving Average 50 Days22.92
Moving Average 200 Days19.73

Statistics

Average Volume5.06M
Shares Outstanding2.69B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.2
Trailing Annual Dividend Yield0.68
Payout Ratio0.09
Last Split Factor3:2
Last Split DateJuly 18, 2023